US Patent Issued to CUROGEN TECHNOLOGY, RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY on March 5 for "Pharmaceutical composition for diagnosing, preventing or treating liver cancer using SSU72 protein or a polynucleotide encoding the same" (South

Press/Media: Research

PeriodMar 6 2024

Media coverage

1

Media coverage

  • TitleUS Patent Issued to CUROGEN TECHNOLOGY, RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY on March 5 for "Pharmaceutical composition for diagnosing, preventing or treating liver cancer using SSU72 protein or a polynucleotide encoding the same" (South
    Media name/outletUS Fed News
    Country/TerritoryUnited States
    Date3/6/24
    PersonsLee Kwan Min
View all 1
View less